Effect of n-3 fatty acids in glycemic and lipid profiles, oxidative stress and total antioxidant capacity in patients with the metabolic syndrome;Efeito dos ácidos graxos n-3 no perfil glicêmico e lipídico, no estresse oxidativo e na capacidade antioxidante total de pacientes com síndrome metabólica

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 5, 2010, Pages 463-469

  Simão, Andréa Name Colado ^a   Godeny, Paula ^a   Lozovoy, Marcell Alysson Batisti ^b   Dichi, Jane Bandeira ^a   Dichi, Isaias ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

Author keywords

Estresse oxidativo; Fish oil; Insulin resistance; Metabolic syndrome; Oxidative stress; leo de peixe; Perfil lip dico; Resist ncia insulina; Serum lipids; S ndrome metab lica

Indexed keywords

EID: 77956717484     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302010000500006     Document Type: Article

References (36)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
2. Wassink AMJ, Olijhoek JK, Visseren FLJ. The metabolic syndrome: metabolic changes with vascular consequences. Eur J Clin Invest. 2007;37(1):8-17.
3. Oliveira EP, Souza MLA, Lima MDA. Prevalência de síndrome metabólica em uma área rural no semi-árido baiano. Arq Bras Endocrinol Metab. 2006;50(3):456-465.
4. Velasquez-Melendez G, Gazzinelli A, Correa-Oliveira R, Pimenta AM, Kac G. Prevalência de síndrome metabólica em área rural do Brasil. São Paulo Med J. 2007;125(3):155-62.
5. Aguilar-Salinas CA, Rojas R, Gómez-Perez FJ, Valles V, Rios-Torres JM, Franco A, et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res. 2004;35:76-81.
6. Gang H, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; for the Decode Study Group. Prevalence of the metabolic syndrome and its relation to all cause and cardiovascular mortality in nondiabetic European men in women. Arch Intern Med. 2004;164:1066-76.
7. Abdilla N, Tormo MC, Fabia MJ, Chaves FJ, Saez G, Redon J. Impact of the components of metabolic syndrome on oxidative stress and enzimatic antioxidant activity in essential hypertension. J Hum Hypertens. 2007;21(1):68-75. Epub 2006 Oct 26.
8. Ohmori K, Ebihara S, Kuriyama S, Ugajin T, Ogata M, Hozawa A, et al. The relationship between body mass index and plasma lipid peroxidation biomarker in an older, healthy Asian community. Ann Epidemiol. 2005;15:80-4.
9. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 2003;88:4673-6.
10. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular dise- ase? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24:816-23.
11. Lee K-U. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract. 2001;54(Suppl 2):29-33.
12. Menon V, Ram M, Dorn J, Armstrong D, Muti P, Freudenheim JL, et al. Oxidative stress and glucose levels in a population-based sample. Diabetic Med. 2004;21:1346-52.
13. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease - fishing for a natural treatmente. BMJ. 2004;328:30-5.
14. Wander RC, Du SH. Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids. Am J Clin Nutr. 2000;72:731-7.
15. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006;83:1237-47.
16. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 1997;20(7):1087-92.
17. Flecha BG, Llesuy S, Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med. 1991;10:93-100.
18. Gonzálvez JAN, Benayas CG, Arenas J. Semiautomated measurement of nitrate in bilogical fluids. Clin Chem. 1998;44:679-81.
19. Oliveira FJA, Cecchini R. Oxidative stress of liver in hamsters infected with Leishmania (L.) Chagasi. J Parasitol. 2000;86(5):1067-72.
20. Barbosa DS, Cecchini R, El Kadri MZ, Rodriguez MA, Burini RC, Dichi I. Decrease oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition. 2003;19:837-41.
21. Jentzsch AM, Bachmann H, Fürst P, Biesalski HK. Improved analysis of malondialdeyde in human body fluids. Free Radic Biol Med. 1996;255:107-10.
22. Repetto M, Reides C, Carretero MLG, Costa M, Griemberg G, Llesuy S. Oxidative stress in blood of HIV infected patients. Clin Chim Acta. 1996;255:107-17.
23. Guevara I, Iwanejko J, Dembinska-Kiéc A, Pankiewicz J, Wanat A, Anna P, et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta. 1998;274:177-88.
24. Lottenberg AMP. Importância da gordura alimentar na prevenção e no controle de distúrbios metabólicos e da doença cardiovascular. Arq Bras Endocrinol Metab. 2009;53(5):595-607.
25. Queiroz JCF, Alonso-Vale MIC, Curi R, Lima FB. Controle da adipogênese por ácidos graxos. Arq Bras Endocrinol Metab. 2009;53(5):582-94.
26. Etherton PMK, Harris WS, Appel LJ; Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106;2747-57.
27. Harris WS, Bulchandani D. Why do ω-3 fatty acids lower serum triglycerides? Curr Opin Lipidol. 2006;17:387-93.
28. Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R. Supression by diets rich in fish oil of very-low-density lipoprotein production in man. J Clin Invest. 1984;74:82-9.
29. Sanders TAB, Sullivan DR, Reeve J, Thompson GR. Triglyceride lowering effects of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis. 1985;5:459-65.
30. Suzukawa M, Abbey M, Howe PRC, Nestel PJ. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J Lipd Research. 1995;36:473-84.
31. Dewailly E, Blanchet C, Lemieux S, Holub BJ. n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr. 2001;74:464-73.
32. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr. 2000;71:1085-94.
33. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 2002;76:1007-15.
34. Meydani M, Evans WJ, Handelman G, Biddle L, Fielding RA, Meydani SN, et al. Protective effect of vitamine E on exerciseinduced oxidative damage in young and older adults. Am J Physiol. 1993;264:R992-998.
35. Casado MF, Cecchini AL, Simão ANC, Oliveira RD, Cecchini R. Free radical-mediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence. Food Chem Toxicol. 2007;45:945-52.
36. Simão ANC, Dichi JB, Barbosa DS, Cecchini R, Dichi I. Influence of uric acid and GGT on total antioxidant capacity and oxidative stress in patients with the metabolic syndrome. Nutrition. 2008;24:675-81.